In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1661 News Items found
Attendees of the fifth annual MSK-CTONG Symposium
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Urge International Harmonization to Accelerate Cancer Drug Approvals at Annual Event

Global regulatory harmonization of clinical trials provides significant opportunity to accelerate access to cancer treatments to benefit all of humanity. This was the theme of the fifth annual MSK-CTONG Symposium, hosted online for a global audience of 20,000 from Guangzhou, China and New York on December 2, 2022.
detail shot of laboratory slides
MSK Research Highlights, December 23, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder cancer; aims to understand the safety of check point inhibitor therapy for patients who are obese; and investigates a potential therapeutic approach against acute myeloid leukemia.
Two photos of Anthony and Arianna Robles
Advanced Colorectal Cancer Treatment Targets KRAS Gene With Drug Combo

MSK investigators led a recent trial that examined a new two-drug combination for patients with advanced colorectal cancer caused by a gene mutation called KRAS-G12C. Research in the lab is focused on how to make these targeted drugs even more effective.
Feature
x-ray of bladder with large tumor
Bladder Preservation in Muscle-Invasive Bladder Cancer Based on DDR Genetic Mutations

MSK researchers are investigating a new way that people with bladder cancer can avoid bladder removal.
In the Lab
Dmitriy Zamarin and Sohrab Shah
MSK Team Focuses on Resistance to Immunotherapy in Ovarian Cancer

A collaborative team from MSK has uncovered important new findings that explain why ovarian cancer does not respond to immunotherapy.
Person in white lab coat using a pipette with a tiny test tube.
Top Cancer Research Advances at MSK in 2022

Read about some of the biggest scientific discoveries made by MSK researchers in 2022.
Feature
(Left to right) Sascha Roth, Luis Diaz, Imtiaz Hussain, Andrea Cercek, Avery Holmes, and Nisha Varughese.
Top Cancer Treatment Advances at MSK in 2022

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Here are some of the most important developments.
Article
MSK head and neck surgeon Marc Cohen and a patient
Questions To Ask an Oncologist During Your First Visit After a Cancer Diagnosis

A cancer diagnosis is life-changing. You might be thinking, “I have cancer, now what?” The first step is to make an appointment with an oncologist — a ...
MSK bile duct cancer patient Berta Pesantez
How MSK Is Making Cancer Clinical Trials in NYC Easier To Access

For many patients, time is of the essence. At MSK, patients have access to potentially lifesaving therapies long before they are available at community hospitals. Learn how MSK’s Cancer Health Equity Research Program (CHERP) partners with a network of public hospitals in New York City to recruit underserved patients for clinical trials at MSK and give them access to world-class care.
Blood samples being prepared for a centrifuge
MSK Research Highlights, ASH Annual Meeting 2022

Numerous developments in cellular therapy, multiple myeloma, leukemia and lymphoma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the American Society of Hematology (ASH) Annual Meeting, which runs December 10-13.